NCT04610801View on ClinicalTrials.gov

Evaluation of the Efficacy of Xylitol Nasal Spray Against SARS-CoV-2

PHASE3WithdrawnINTERVENTIONAL
0
Timeline

Start Date

December 8, 2021

Primary Completion Date

June 8, 2022

Study Completion Date

August 8, 2022

Conditions
Covid19
Interventions
DRUG

Nasal Spray

Randomized to placebo and Xlear

Trial Locations (2)

33012

Larkin Community Hospital Palm Springs Campus, Miami

33143

Larkin Community Hospital, Miami

Sponsors
All Listed Sponsors
collaborator

Ferrer Medical Innovations

UNKNOWN

collaborator

Xlear, Inc

INDUSTRY

lead

Larkin Community Hospital

OTHER

NCT04610801 - Evaluation of the Efficacy of Xylitol Nasal Spray Against SARS-CoV-2 | Biotech Hunter | Biotech Hunter